NEU 0.07% $20.24 neuren pharmaceuticals limited

Evans partners report on Neu

  1. 2,276 Posts.
    lightbulb Created with Sketch. 1813
    Evans and Partners have come out with a report on Neuren ,with a current valuation of $5.40 and upside to $7.70 if trofinetide is successful.Only clients of Evans have access to the report .
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.24
Change
-0.015(0.07%)
Mkt cap ! $2.591B
Open High Low Value Volume
$20.40 $20.50 $20.17 $1.852M 91.25K

Buyers (Bids)

No. Vol. Price($)
3 6 $20.23
 

Sellers (Offers)

Price($) Vol. No.
$20.24 191 14
View Market Depth
Last trade - 13.10pm 08/05/2024 (20 minute delay) ?
Last
$20.07
  Change
-0.015 ( 0.80 %)
Open High Low Volume
$20.45 $20.50 $20.05 30926
Last updated 13.30pm 08/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.